Marina Elena Cazzaniga, MDNovember 21, 2025

FDA 483 - Marina Elena Cazzaniga, MD - November 21, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Marina Elena Cazzaniga, MD

Record Details

Marina Elena Cazzaniga, MD, a clinical investigator in Monza, Italy, was cited for significant deficiencies in conducting clinical studies. The inspection revealed multiple discrepancies between source documents and electronic Case Report Forms (eCRF) for investigational drug subjects, indicating poor data integrity. Additionally, the firm failed to obtain proper informed consent for the collection of biological samples from two subjects.

Company: Marina Elena Cazzaniga, MD
Inspection Date: November 21, 2025
Product Type: Drugs
Office: Office of Inspections and Investigations
Person: Yuanyuan Li (issuing_officer)

Open in Dashboard

ID · b1ce4ccc-0b64-40a3-94c4-d31931b49f50